The role of statins in prevention and treatment of the Alzheimer disease Review article
Article Sidebar
Main Article Content
Abstract
With the ageing of the global population chronic diseases are more and more common, also those including deterioration of central nervous system. From those the Alzheimer disease remain to terrify patients the most. Nowadays in some patients we are ably only to slow the degeneration process that occurs within the nervous system. New ways of treatment are still needed. There are some date from laboratory experiments and clinical trials showing that pleiotropic effects of statins can be use in prevention or treatment of Alzheimer disease. The authors of this article describe some of hypothetic biological mechanisms in which statins can have neuroprotection effect. Authors present also short review of the most important clinical trials relating to this issue.
Article Details
Copyright © by Medical Education. All rights reserved.
References
2. Pawełczyk T., Kłoszewska I.: Czy statyny znajdują zastosowanie w chorobie Alzheimera? Postępy Psychiatrii i Neurologii 2005; 14(3): 209-216.
3. Jick H., Zornberg G.L., Jick S.S., Seshadri S., Drachman D.A.: Statins and the risk of dementia. Lancet 2000; 356(9242): 1627-31.
4. Rockwood K., Kirkland S., Hogan D.B., MacKnight C., Merry H., Verreault R., Wolfson C., McDowell I.: Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Arch. Neurol. 2002; 59(2): 223-7.
5. Hajjar I., Schumpert J., Hirth V., Wieland D., Eleazer G.P.: The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. J. Gerontol. A Biol. Sci. Med. Sci. 2002; 57(7): M414-8.
6. McNaull B.B.A., Todd S., McGuinness B., Passmore A.P.: Inflammation and Anti-Inflammatory Strategies for Alzheimer’s Disease – A Mini-Review.Gerontology 2010; 56: 3-14.
7. Galus R., Zandecki Ł., Jóźwiak J., Włodarski K.: Pozalipidowe działanie statyn. Pol. Merk. Lek. 2008; XXIV (144): 545.
8. Sparks D.L. et al.: Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch. Neurol. 2005 May; 62(5):753-7.
9. Feldman H.H. et al.; On behalf of the LEADe Investigators: Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease. LEADe. Neurology [online: doi:10.1212/WNL.0b013e3181d6476a].